Cargando…
Dupilumab therapy following JAK inhibitor withdrawal in moderate–severe atopic dermatitis
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons, Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9787163/ https://www.ncbi.nlm.nih.gov/pubmed/35906850 http://dx.doi.org/10.1111/dth.15750 |